Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
America’s Grocery Carts Are Getting a Health Check: New Data from FoodHealth Co. and NielsenIQ Reveal What We’re Really Eating
-
Syndeio Biosciences Appoints Aaron Koenig, M.D., as Chief Medical Officer
-
Zenmuse L3 Launches as DJI's First Long-Range, High-Accuracy Aerial LiDAR System
-
Attralus To Present Phase 1/2 Data on Its Pan Amyloid Depleter at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
-
CIMG Inc. Authorizes Individual Shareholder's Equity Tokenization with FlowStocks
-
Seaport Therapeutics to Present at Stifel 2025 Healthcare Conference
-
Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of MammaPrint + BluePrint at the 2025 San Antonio Breast Cancer Symposium
-
Vertical Aerospace Provides Third Quarter Update, Demonstrating Momentum on Transition Flight Testing, Business Plan Updates and Best-in-Class Aircraft
-
Ezurio Launches the Nitrogen HMI: U.S. Built, Pre-Certified HMI for Industrial, Commercial, and Medical Applications
-
Spendesk Expands Into Corporate Travel With a Unified Spend Platform for Booking, Payment, and Control
-
Harley-Davidson Delivers Third Quarter Financial Results
-
Eptura Expands Capabilities to Reach Users Wherever They Work, Scale Operational Efficiency, and Extend Data and Analytics Ecosystems
-
Bowhead Specialty Holdings Inc. Reports Third Quarter 2025 Results
-
Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
-
NexGold Achieves Critical Permitting Milestone; Receives Final Federal Approval for the Goldboro Gold Project
-
Echo Concludes Six-Part Hydrogen Water Performance Series Highlighting the Cellular Impact of Molecular Hydrogen
-
Yum! Brands Reports Third-Quarter Results
-
Binary Defense Appoints Dr. Aaron Estes as Vice President of Product
-
Summit Therapeutics to Present at Upcoming Investor Conferences
-
Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Perion Launches DOOH Player, Completing the Full-Stack Marketing Operating System for DOOH and Retail Media
-
Ambetter from WellCare of Kentucky Offers Health Insurance in Kentucky in 2026
-
Nature Communications Study Supports HER2DX as a Genomic Tool for Tailored Therapy in Older Individuals With HER2+ Breast Cancer
-
Boardable Unveils Fall Release: Engagement Dashboards, New AI Tools & Meeting Insights
-
NEOK Bio Launches from Stealth with $75 Million Series A to Advance Next-Generation Bispecific Antibody Drug Conjugates (ADC) in Oncology
-
Silver Storm Completes Drawdown of US$7.0M Prepaid Offtake Facility With Samsung C&T
-
TEN (Transportation Equipment Network) Names Hooman Yazhari as Chief Executive Officer
-
United Therapeutics Corporation to Present at Upcoming Investor Conferences
-
Intruder Named Cloud Security Innovator in Latio’s 2025 Cloud Security Market Report
-
WeRide Announces Pricing of Global Offering
-
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
-
White Gold Corp. Increases High-grade Gold Mineralization at Golden Saddle Intersecting 6.9 g/t Gold over 50.2 Metres in the Main Zone and Expands the High-Grade Footwall Breccia and Hanging Wall Mine
-
CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies
-
Plug To Announce 2025 Third Quarter Results on November 10, 2025
-
Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2025
-
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
-
NCPA and USC Launch First Publicly Available Tool to Identify Pharmacy Shortage Areas Across America
-
Amplify ETFs Launches the Amplify Solana 3% Monthly Option Income ETF (SOLM)
-
LGI Homes, Inc. Reports Third Quarter 2025 Results
-
N2K CyberWire network welcomes Rubrik's Data Security Decoded podcast
-
Stewards Inc. Announces $10 Million Private Placement With Dolomite Foundation to Advance Digital Asset Strategy
-
MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
-
Colliers Reports Third Quarter Results
-
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
-
Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada
-
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
-
Sotera Health Reports Strong Third-Quarter and Year-to-Date 2025 Results
-
Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update
-
Ero Announces Result of Year-Long Value-Creation Initiative at Xavantina, Commences First Gold Concentrate Sales in Q4 2025
-
Exact Sciences to Participate in November Investor Conference


